Leila Luheshi
Vice President, Pharma Partnering OGT, a Sysmex Group Company
Seminars
Thursday 25th September 2025
Finding Clarity From Complexity: Unlocking the Next Generation of Precision Medicines for Hematological Cancers with Tailored Diagnostic Solutions
11:00 am
- Developing effective precision medicines for hematological cancers poses many complex challenges for biomarker and CDx strategists
- Success depends on finding partners with the hematopathology expertise and technology platforms to develop innovative diagnostic solutions that bring elevated accuracy
- Learn how you can leverage Sysmex’s 50+ years as the global leader in developing and commercializing hematology diagnostics to accelerate your biomarker and CDx strategies
